Pharma IQ Members

Anti-Interferon

Anti-Interferon is an antibody to an interferon. It is used for the purification of interferons. The untoward effects of the interferons can be reversed or prevented by simultaneously adding anti-interferon (usually an antibody). This helps in treating many diseases, especially viral infections.

19 results
of 2
The R&D Race behind Immune Checkpoint Modulators

The cancer immunotherapy market is primed for growth, with Immune Checkpoint Inhibitors, otherwise known as Immune Checkpoint Modulators, representing one of the area’s newest and most promising treatments. While also incorporating the focus on...

Contributor: Chanice Henry
Sat, 11/14/2015
Pharma IQ News

The launch of interferon-free regimens is expected to boost the hepatitis C market from $2.9bn in 2013 to a peak of $19.2bn in 2016, according to independent analysts Datamonitor Healthcare.

The superior efficacy and tolerability of oral...

Contributor: Pharma IQ News
Tue, 07/01/2014
Boehringer Ingelheim's Johannes Schoen on How to Prepare for the Falsified Medicines Directive

In this recent interview, Johannes Schoen, Supply Network Quality Management Anti-Counterfeitng, Boehringer Ingelheim speaks to Andrea Charles from Pharma IQ, following facilitating the "Anti-Counterfeiting: Falsified Medicines Directive and...

Mon, 02/18/2013
How Can We Still Deliver an Effective Anti-Counterfeiting Program When Facing Cost Restraints?

Cases of counterfeit pharmaceuticals being discovered entering the United States are on the up.

Up 200 percent to $11 million (£7 million) in 2011 to be precise, based on the domestic value of seizures from the Customs and Border Protection...

Contributor: Pharma IQ
Thu, 01/26/2012
Pharma IQ

"Fraudulent medicines offer organised criminal groups a high return commodity with relatively low risks, ultimately at the expense of the health of unsuspecting people," Yury Fedotov, executive director of the United Nations Office on Drugs and...

Contributor: Pharma IQ
Wed, 06/08/2011
Pharma IQ News

Cranbury, New Jersey, May 24, 2011- Systech International, innovator of Packaging Execution Systems (PES), and our Brazilian Partner Videojet today announced that one of the world’s largest pharmaceutical manufacturers has chosen to implement...

Contributor: Pharma IQ News
Tue, 05/24/2011
Helen Winsor

Mark Gibson, Consumer Information Specialist at Gibson Research Consultancy, joins Helen Winsor form Pharma IQ, to discuss packaging and labelling in the healthcare industry. In this exclusive interview, Gibson outlines the main considerations in...

Contributor: Helen Winsor
Sat, 05/07/2011
Pharma IQ

With the performance of new and existing IPs potentially being the difference between success and failure in the modern business world, it is arguably more important than ever that these are protected from criminals. Counterfeiters are constantly...

Contributor: Pharma IQ
Wed, 02/16/2011
Helen Winsor

James McBlane, Preclinical Assessor in the Clinical Trials Unit, Medicines & Healthcare products Regulatory Agency (MHRA), joins Pharma IQ to discuss clinical trials in patients with advanced cancer, ahead of the 2nd Annual Optimising...

Contributor: Helen Winsor
Mon, 01/17/2011
Pharma IQ News

Mark Edwards, Global Freight Manager from Actavis and John Franks, Security Director EMEA from Merck Sharp & Dohme, joined forces in order to explore how patient safety could be improved by protecting pharmacies and distributors from supply...

Contributor: Pharma IQ News
Wed, 01/05/2011
19 results
of 2